Medicis Pharma (MRX) Reports In-Line Q4 EPS of 60c; Guides Q1
Tweet Send to a Friend
Medicis Pharmaceutical Corp. (NYSE: MRX) reported Q4 EPS of $0.60 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
